507
Participants
Start Date
April 30, 2005
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Nilotinib
Novartis Investigative Site, Brussels
Novartis Investigative Site, Geneva
Novartis Investigative Site, St Leonards
Novartis Investigative Site, Leuven
Novartis Investigative Site, Prahran
Novartis Investigative Site, Basel
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Yvoir
Novartis Investigative Site, Haine-Saint-Paul
Memorial Sloan Kettering Cancer Center, New York
Novartis Investigative Site, Orbassano
Novartis Investigative Site, Marseille
Novartis Investigative Site, Berlin
Roswell Park Cancer Institute Rosewell SC, Buffalo
University of Rochester Medical Center, Rochester
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Monza
Novartis Investigative Site, Dijon
Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Div.of Hematologic Malignancie, Baltimore
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Pavia
Wake Forest University Baptist Medical Center, Winston-Salem
Duke University Medical Center, Durham
Novartis Investigative Site, Bordeaux
H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt, Tampa
Novartis Investigative Site, Rennes
Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services, Nashville
The Jones Clinic, Germantown
Novartis Investigative Site, Bologna
Novartis Investigative Site, Düsseldorf
Indiana Blood and Marrow Institute Dept of Indiana Blood&Mar (2), Beech Grove
University of Michigan Health System Clinical Trials Office, Ann Arbor
Wayne State University, Detroit
Novartis Investigative Site, Vandœuvre-lès-Nancy
Novartis Investigative Site, Mainz
Mayo Clinic - Rochester, Rochester
Novartis Investigative Site, Lille
Novartis Investigative Site, Frankfurt/M
University of Chicago Medical Center Dept. of U. of Chicago Hosp(3), Chicago
Novartis Investigative Site, Pescara
Novartis Investigative Site, Mannheim
Novartis Investigative Site, Lyon
Ochsner Clinic Foundation, New Orleans
MD Anderson Cancer Center/University of Texas, Houston
University of Colorado Hospital, Aurora
Novartis Investigative Site, Napoli
Novartis Investigative Site, München
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Poitiers
Novartis Investigative Site, Limoges
Novartis Investigative Site, Reggio Calabria
City of Hope National Medical Center, Duarte
Novartis Investigative Site, Créteil
Oregon Health Sciences University, Portland
Swedish Cancer Institute, Seattle
Novartis Investigative Site, Singapore
Stanford University Medical Center, Stanford
University of Illinois at Chicago Divisionof Hematology/Oncology, Chicago
Novartis Investigative Site, Pokfulam
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Grafton
Dana Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
Novartis Investigative Site, Vienna
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Novartis Investigative Site, Vejle
Novartis Investigative Site, HUS Helsinki
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Oslo
Novartis Investigative Site, Katowice
Novartis Investigative Site, Lodz
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Hwasun-gun
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Taegu
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Linköping
Novartis Investigative Site, Lund
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Glasgow - Scotland
Novartis Investigative Site, Leeds
Novartis Investigative Site, Liverpool
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Newcastle upon Tyne
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY